Immediate Impact
58 standout
Citing Papers
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Works of Tzu-Tao Chen being referenced
Bevacizumab Reduces S100A9-Positive MDSCs Linked to Intracranial Control in Patients with EGFR-Mutant Lung Adenocarcinoma
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Tzu-Tao Chen | 119 | 111 | 27 | 56 | 25 | 298 | |
| Maria Malmlöf | 156 | 96 | 33 | 43 | 14 | 310 | |
| Fuhai Shen | 163 | 74 | 15 | 24 | 38 | 332 | |
| Filippo Cellai | 43 | 59 | 25 | 46 | 27 | 277 | |
| Christina Umbright | 113 | 106 | 38 | 10 | 19 | 315 | |
| Heba M. Adly | 54 | 67 | 25 | 37 | 36 | 310 | |
| Jinjin Hao | 46 | 90 | 16 | 25 | 27 | 319 | |
| Run Xu | 54 | 110 | 18 | 43 | 17 | 301 | |
| Yan Xu | 106 | 23 | 29 | 25 | 39 | 315 | |
| David Scoville | 26 | 51 | 21 | 20 | 20 | 234 | |
| Yijun Deng | 52 | 44 | 11 | 11 | 19 | 301 |
All Works
Loading papers...